HealthX Backs Vinyl Health’s $2M Bet That Patients Should Own the Record

Vinyl Health has raised $2M in Seed funding led by HealthX Ventures, the Marlton, New Jersey company announced October 20, 2026. The capital supports a broader public launch and continued development of its AI personal health assistant, available on iOS and Android. HealthX Ventures, a Madison, Wisconsin firm focused on digital healthcare, brings operating support and relationships across providers, payers and employers to an investment in software controlled by the patient.

Vinyl’s commercial opportunity, as the source frames it, sits in making information usable after the encounter: helping a patient understand the plan, bring a family member into it and carry relevant context into the next conversation. The app combines visit capture, medical information and patient-directed sharing. Its described features include notes from recorded visits, a care plan, a question list, a journal and tools for requesting practical support. A family member can contribute a question before a visit, while the patient decides what information gets shared.

That sharing model extends the record to several audiences. A patient may want a plain-language explanation; a clinician needs relevant medical detail; a relative may need to know how to help. Vinyl also describes support requests for meals, rides and other everyday needs, and a caregiver workflow with shared updates and organized information for people helping relatives with complex or ongoing needs. The source presents these as company-described capabilities and intended uses, not as measured reductions in admissions, costs or missed appointments.

Founder and CEO Dr. Kaitlan Baston brings experience in primary care, addiction medicine, public health and hospital leadership; she previously served as New Jersey’s health commissioner and led University Hospital in Newark. Vinyl’s leadership page identifies Nilesh Bhandari as co-founder and CPO, Eric Uhe as co-founder and CTO, and Justin Recklau as COO and CFO. Bhandari’s remit includes reaching individuals directly and building a product that employers and payers may eventually extend to members, giving Vinyl more than one prospective route to users.

HealthX’s role places institutional connections beside a consumer product. The source cites Managing Partner Mark Bakken’s emphasis on visit documentation and the patient’s attention: someone can listen to the doctor rather than concentrate on retaining every detail. The announcement does not identify an employer rollout or health-plan contract, and Vinyl has not disclosed valuation, individual investor allocations or a detailed spending schedule.

An earlier Form D filed in June 2026 disclosed $1M sold within a larger offering. The relationship between that filing and October’s $2M announcement is unspecified; adding the figures would manufacture a lifetime funding total the company has not supplied.